Host immune potentiation of drug responses to a murine mammary adenocarcinoma.
D000230:Adenocarcinoma / Q000188:drug therapy / Q000276:immunology*; D000818:Animals; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D002470:Cell Survival / Q000187:drug effects; D002471:Cell Transformation, Neoplastic / Q000187:drug effects; D003520:Cyclophosphamide / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D007165:Immunosuppression Therapy; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy / Q000276:immunology*; D008558:Melphalan / Q000494:pharmacology / Q000627:therapeutic use*; D051379:Mice; D008811:Mice, Inbred DBA; D013997:Time Factors
D000961:Antilymphocyte Serum; D003520:Cyclophosphamide; D008558:Melphalan